CR Bard Earns $1.91 Per Share

After the closing bell, CR Bard ($BCR) reported first-quarter earnings of $1.91 per share. That beat estimates by seven cents per share. Bard had told us to expect earnings between $1.83 and $1.87 per share so this is an impressive beat. Sales rose 8% to 799.3 million. Sales in the U.S. rose 11% and foreign sales were up 3%.

CEO Timothy M. Ring said, “The financial results in the first quarter reflect a positive start to the year, as we exceeded our expectations for both sales and earnings per share. The organization is focused on executing our strategic investment plan with the objective of improving the long-term growth profile of the business.”

The press release describes Bard as “a leading multinational developer, manufacturer and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology and surgical specialty products.”

Posted by on April 22nd, 2014 at 4:31 pm

The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.